Medical Affairs & Scientific Strategy
As the role of medical affairs continues to be acknowledged for its function as a primary strategic organizational pillar, life sciences companies must empower medical affairs to bridge the scientific gap by generating and communicating clinical knowledge to stakeholders and patients. These organizations must also develop strategies that align medical affairs activities with core business goals that are supported by outcomes research and real-world evidence (RWE) for their products or therapeutics to be successful in the market.
At Baker Tilly, our team of life sciences industry specialists have foresight into the future state of medical affairs and provide the strategic lens that medical device and pharmaceutical companies need to achieve success now, and tomorrow.
Our team is made up of professionals including epidemiologists and other scientists who have conducted research across a wide range of settings and disease states. We also operate across therapeutic areas and patient populations to identify and develop a medical and scientific strategy for your brand that blends scientific and operational objectives to help you and your organization achieve your medical affairs goals.
With our years of real-world and practical experience, we are able to provide clarity and timely advice that addresses your company’s specific and unique challenges. With this burden of navigating nuanced scenarios taken off your plate, your team can focus its time and energy on important transitions and your organization’s journey of accomplishing its strategic goals.
Baker Tilly’s team of specialized professionals are prepared to support you and your company with a wide range of medical affairs solutions, including establishing medical launch teams, developing scientific communication platforms and defining your evidence-generation strategies, all while managing risk and developing guardrails to support your field teams.
Baker Tilly’s medical affairs specialists can work with you and your medical teams as well as brand leadership to develop a comprehensive medical strategy that is aligned to your brand objectives, including planning for evidence generation, engaging with key opinion leaders (KOLs) and aligning your medical affairs team with your commercial function.
Baker Tilly can help evaluate your evidence landscape across your therapeutic area to identify gaps, weaknesses, and opportunities related to generating new clinical and economic evidence to support your brand and portfolio objectives.
Baker Tilly can conduct an in-depth assessment of your organization’s clinical, medical, and scientific processes to identify gaps and weaknesses in the governance environment, including policies, procedures, training, and change management processes. We also work with key stakeholders to secure coverage of medical and scientific risk areas, including:
Baker Tilly understands that life sciences companies can succeed when they have taken steps to ensure studies are well designed, executed and published. We understand because we have also been there. From concept to protocol to generating conclusions, Baker Tilly can collaborate with you each step of the way to strategically help you through the study design and data analysis process.
Baker Tilly provides senior clinical and scientific advisory experience to fulfill the requirements of vacant and under-resourced scientific leadership roles, including clinical development, medical affairs, health economics and outcomes research (HEOR), chief medical officers (CMOs) and more.
Baker Tilly can evaluate your organization’s scientific communication platform and assets to identify and optimize the scientific narrative and value proposition, develop assets, plan for publication, and develop tools for managing scientific references and claims.
Baker Tilly understands that your field team is a key pillar of your business as they navigate coordinating with other field needs with promotional functions. We also understand that field representatives have unique key performance indicators (KPIs) and goals that vary across departments and positions. At Baker Tilly, we can work with your field teams to define the importance of strategic account management while clearly identifying guardrails to separate promotional and nonpromotional objectives.
It is critical for life sciences companies to build relationships with thought leaders who can influence the opinions and behaviors of HCPs and patients. However, it can often be hard to find KOLs and build relationships prior to an engagement. Furthermore, for each instance that you may need a thought leader, you should have a KOL identified, picked, evaluated and compliance implications considered.
At Baker Tilly, our proprietary technology, kolNOW™ , can help with the KOL identification, evaluation and selection process. With access to more than 10 million pre-tiered KOLs around the world, our team and technology can meet your KOL engagement goals as well as compliance requirements.